Jürgen Wess - Publications

Affiliations: 
NIDDK, National Institutes of Health 

285 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Balla H, Borsodi K, Őrsy P, Horváth B, Molnár PJ, Lénárt Á, Kosztelnik M, Ruisanchez É, Wess J, Offermanns S, Nyirády P, Benyó Z. Intracellular signaling pathways of muscarinic acetylcholine receptor-mediated detrusor muscle contractions. American Journal of Physiology. Renal Physiology. PMID 37675459 DOI: 10.1152/ajprenal.00261.2022  0.448
2023 Zheng F, Wess J, Alzheimer C. Long-Term-But Not Short-Term-Plasticity at the Mossy Fiber-CA3 Pyramidal Cell Synapse in Hippocampus Is Altered in M1/M3 Muscarinic Acetylcholine Receptor Double Knockout Mice. Cells. 12. PMID 37508553 DOI: 10.3390/cells12141890  0.43
2023 Wess J. The third intracellular loop of GPCRs: size matters. Trends in Pharmacological Sciences. PMID 37208206 DOI: 10.1016/j.tips.2023.05.001  0.348
2022 Meister J, Bone DBJ, Knudsen JR, Barella LF, Velenosi TJ, Akhmedov D, Lee RJ, Cohen AH, Gavrilova O, Cui Y, Karsenty G, Chen M, Weinstein LS, Kleinert M, Berdeaux R, ... ... Wess J, et al. Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nature Communications. 13: 22. PMID 35013148 DOI: 10.1038/s41467-021-27540-w  0.308
2021 Wess J. In Vivo Metabolic Roles of G Proteins of the Gi Family Studied with Novel Mouse Models. Endocrinology. PMID 34871353 DOI: 10.1210/endocr/bqab245  0.327
2020 Wang L, Zhu L, Meister J, Bone DBJ, Pydi SP, Rossi M, Wess J. Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs. Annual Review of Pharmacology and Toxicology. PMID 32746768 DOI: 10.1146/Annurev-Pharmtox-030220-121042  0.405
2020 Pydi SP, Jain S, Barella LF, Zhu L, Sakamoto W, Meister J, Wang L, Lu H, Cui Y, Gavrilova O, Wess J. β-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia. Science Advances. 6: eaba1733. PMID 32548266 DOI: 10.1126/Sciadv.Aba1733  0.329
2020 Wang L, Pydi SP, Zhu L, Barella LF, Cui Y, Gavrilova O, Bence KK, Vernochet C, Wess J. Adipocyte G signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity. Nature Communications. 11: 2995. PMID 32532984 DOI: 10.1038/S41467-020-16756-X  0.345
2020 Zhu L, Rossi M, Doliba NM, Wess J. Beta-cell M muscarinic acetylcholine receptors as potential targets for novel antidiabetic drugs. International Immunopharmacology. 81: 106267. PMID 32044662 DOI: 10.1016/J.Intimp.2020.106267  0.379
2020 Dattaroy D, Barella LF, Pydi SP, Cui Y, Kaestner KH, Wess J. 2129-P: Glucagon Secretion from Pancreatic Islets Is Regulated by Beta-Arrestin-1 Diabetes. 69. DOI: 10.2337/Db20-2129-P  0.359
2020 Pydi SP, Jain S, Barella LF, Meister J, Wang L, Cui Y, Gavrilova O, Wess J. 1694-P: Beta-Arrestin 1 Suppresses Myogenic Reprogramming of Brown Fat to Maintain Euglycemia Diabetes. 69. DOI: 10.2337/Db20-1694-P  0.382
2019 Meister J, Bone DBJ, Godlewski G, Liu Z, Lee RJ, Vishnivetskiy SA, Gurevich VV, Springer D, Kunos G, Wess J. Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice. Plos Genetics. 15: e1008424. PMID 31622341 DOI: 10.1371/Journal.Pgen.1008424  0.369
2019 Burczyk MS, Burkhalter MD, Tena TC, Grisanti LA, Kauk M, Matysik S, Donow C, Kustermann M, Rothe M, Cui Y, Raad F, Laue S, Moretti A, Zimmermann WH, Wess J, et al. Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafish. Jci Insight. 4. PMID 31619590 DOI: 10.1172/Jci.Insight.121971  0.456
2019 Trivedi G, Inoue D, Chen C, Bitner L, Chung YR, Taylor J, Gönen M, Wess J, Abdel-Wahab O, Zhang L. Muscarinic acetylcholine receptor regulates self-renewal of early erythroid progenitors. Science Translational Medicine. 11. PMID 31554738 DOI: 10.1126/Scitranslmed.Aaw3781  0.406
2019 Zhu L, Rossi M, Cohen A, Pham J, Zheng H, Dattaroy D, Mukaibo T, Melvin JE, Langel JL, Hattar S, Matschinsky FM, Appella DH, Doliba NM, Wess J. Allosteric modulation of β-cell M muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 31451647 DOI: 10.1073/Pnas.1904943116  0.394
2019 Wang L, Pydi SP, Cui Y, Zhu L, Meister J, Gavrilova O, Berdeaux R, Fortin JP, Bence KK, Vernochet C, Wess J. Selective activation of G signaling in adipocytes causes striking metabolic improvements in mice. Molecular Metabolism. PMID 31272886 DOI: 10.1016/J.Molmet.2019.06.018  0.322
2019 Pydi SP, Jain S, Tung W, Cui Y, Zhu L, Sakamoto W, Jain S, Abel BS, Skarulis MC, Liu J, Huynh T, Pacak K, Caron MG, Gavrilova O, Finkel T, ... Wess J, et al. Adipocyte β-arrestin-2 is essential for maintaining whole body glucose and energy homeostasis. Nature Communications. 10: 2936. PMID 31270323 DOI: 10.1038/S41467-019-11003-4  0.351
2019 Barella LF, Rossi M, Zhu L, Cui Y, Mei FC, Cheng X, Chen W, Gurevich VV, Wess J. β-Cell-intrinsic β-arrestin 1 signaling enhances sulfonylurea-induced insulin secretion. The Journal of Clinical Investigation. 130. PMID 31184597 DOI: 10.1172/Jci126309  0.319
2019 Zhu L, Dattaroy D, Pham J, Wang L, Barella LF, Cui Y, Wilkins KJ, Roth BL, Hochgeschwender U, Matschinsky FM, Kaestner KH, Doliba NM, Wess J. Intra-islet glucagon signaling is critical for maintaining glucose homeostasis. Jci Insight. 5. PMID 31012868 DOI: 10.1172/Jci.Insight.127994  0.379
2019 Bone DBJ, Meister J, Knudsen JR, Dattaroy D, Cohen A, Lee R, Lu H, Metzger D, Jensen TE, Wess J. Skeletal Muscle-Specific Activation of G Signaling Maintains Glucose Homeostasis. Diabetes. PMID 30936140 DOI: 10.2337/Db18-0796  0.37
2019 WANG L, PYDI SP, ZHU L, JAIN S, CUI Y, GAVRILOVA O, WESS J. 1781-P: Adipocyte GI Signaling Regulates Whole-Body Glucose Homeostasis and Insulin Sensitivity Diabetes. 68: 1781-P. DOI: 10.2337/Db19-1781-P  0.354
2019 Vincent SG, Bone D, Wess J, Fisher JT. Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences European Respiratory Journal. 54. DOI: 10.1183/13993003.Congress-2019.Pa2028  0.455
2018 Romberg C, Bartko S, Wess J, Saksida LM, Bussey TJ. Impaired object-location learning and recognition memory but enhanced sustained attention in M2 muscarinic receptor-deficient mice. Psychopharmacology. PMID 30327842 DOI: 10.1007/S00213-018-5065-7  0.52
2018 Kaiser E, Tian Q, Wagner M, Barth M, Xian W, Schroeder L, Ruppenthal S, Kaestner L, Boehm U, Wartenberg P, Lu H, McMillin SM, Bone DB, Wess J, Lipp P. DREADD technology reveals major impact of Gq signaling on cardiac electrophysiology. Cardiovascular Research. PMID 30321287 DOI: 10.1093/Cvr/Cvy251  0.348
2018 Welliver RR, Polanco JJ, Seidman RA, Sinha AK, O'Bara MA, Khaku ZM, Santiago González DA, Nishiyama A, Wess J, Feltri ML, Paez PM, Sim FJ. Muscarinic receptor MR signaling prevents efficient remyelination by human and mouse oligodendrocyte progenitor cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29959237 DOI: 10.1523/Jneurosci.1862-17.2018  0.482
2018 Klawonn AM, Wilhelms DB, Lindström SH, Singh AK, Jaarola M, Wess J, Fritz M, Engblom D. Muscarinic M4 Receptors on Cholinergic and Dopamine D1 Receptor-Expressing Neurons Have Opposing Functionality for Positive Reinforcement and Influence Impulsivity. Frontiers in Molecular Neuroscience. 11: 139. PMID 29740282 DOI: 10.3389/fnmol.2018.00139  0.335
2018 Deckmann K, Rafiq A, Erdmann C, Illig C, Durschnabel M, Wess J, Weidner W, Bschleipfer T, Kummer W. Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201700582R. PMID 29401598 DOI: 10.1096/Fj.201700582R  0.548
2018 Grundmann M, Merten N, Malfacini D, Inoue A, Preis P, Simon K, Rüttiger N, Ziegler N, Benkel T, Schmitt NK, Ishida S, Müller I, Reher R, Kawakami K, Inoue A, ... ... Wess J, et al. Lack of beta-arrestin signaling in the absence of active G proteins. Nature Communications. 9: 341. PMID 29362459 DOI: 10.1038/S41467-017-02661-3  0.354
2018 Rossi M, Zhu L, McMillin SM, Pydi SP, Jain S, Wang L, Cui Y, Lee RJ, Cohen AH, Kaneto H, Birnbaum MJ, Ma Y, Rotman Y, Liu J, Cyphert TJ, ... ... Wess J, et al. Hepatic Gi signaling regulates whole-body glucose homeostasis. The Journal of Clinical Investigation. PMID 29337301 DOI: 10.1172/Jci94505  0.323
2018 PYDI SP, WESS J. Adipocyte-Selective Deletion of ß-Arrestin-1 in Mice Causes Adiposity, Impaired Glucose Tolerance, and Reduced Insulin Sensitivity Diabetes. 67: 2034-P. DOI: 10.2337/Db18-2034-P  0.363
2018 JAIN S, WESS J, JACOBSON KA. Polymorphic Role of P2Y6Receptor in Insulin Sensitive Organs—Adipose Tissue and Skeletal Muscle Diabetes. 67: 1769-P. DOI: 10.2337/Db18-1769-P  0.353
2018 ZHU L, WESS J. A Positive Allosteric Modulator Enhances the Ability of Beta Cell M3 Muscarinic Receptors to Simulate Insulin Secretion In Vitro and In Vivo Diabetes. 67: 1767-P. DOI: 10.2337/Db18-1767-P  0.442
2017 Moehle MS, Pancani T, Byun N, Yohn SE, Wilson GH, Dickerson JW, Remke DH, Xiang Z, Niswender CM, Wess J, Jones CK, Lindsley CW, Rook JM, Conn PJ. Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor. Neuron. 96: 1358-1372.e4. PMID 29268098 DOI: 10.1016/J.Neuron.2017.12.008  0.455
2017 Gould RW, Grannan MD, Gunter BW, Ball J, Bubser M, Bridges TM, Wess J, Wood MW, Brandon NJ, Duggan ME, Niswender CM, Lindsley CW, Conn PJ, Jones CK. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M4 PAM VU0467154. Neuropharmacology. PMID 28729220 DOI: 10.1016/J.Neuropharm.2017.07.013  0.426
2017 Zhu L, Rossi M, Cui Y, Lee RJ, Sakamoto W, Perry NA, Urs NM, Caron MG, Gurevich VV, Godlewski G, Kunos G, Chen M, Chen W, Wess J. Hepatic β-arrestin 2 is essential for maintaining euglycemia. The Journal of Clinical Investigation. PMID 28650340 DOI: 10.1172/Jci92913  0.31
2017 Akhmedov D, Mendoza-Rodriguez MG, Rajendran K, Rossi M, Wess J, Berdeaux R. Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling. Molecular and Cellular Biology. 37. PMID 28167604 DOI: 10.1128/Mcb.00584-16  0.398
2017 Calcutt NA, Smith DR, Frizzi K, Sabbir MG, Chowdhury SK, Mixcoatl-Zecuatl T, Saleh A, Muttalib N, Van der Ploeg R, Ochoa J, Gopaul A, Tessler L, Wess J, Jolivalt CG, Fernyhough P. Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. The Journal of Clinical Investigation. PMID 28094765 DOI: 10.1172/Jci88321  0.376
2016 Bradley SJ, Bourgognon JM, Sanger HE, Verity N, Mogg AJ, White DJ, Butcher AJ, Moreno JA, Molloy C, Macedo-Hatch T, Edwards JM, Wess J, Pawlak R, Read DJ, Sexton PM, et al. M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss. The Journal of Clinical Investigation. PMID 27991860 DOI: 10.1172/Jci87526  0.448
2016 Leaderbrand K, Chen HJ, Corcoran KA, Guedea AL, Jovasevic V, Wess J, Radulovic J. Muscarinic acetylcholine receptors act in synergy to facilitate learning and memory. Learning & Memory (Cold Spring Harbor, N.Y.). 23: 631-638. PMID 27918283 DOI: 10.1101/Lm.043133.116  0.397
2016 Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, Patel S, Marnett LJ, Niswender CM, Jones CK, Xiang Z, Lindsley CW, Rook JM, Conn PJ. Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release. Neuron. PMID 27618677 DOI: 10.1016/J.Neuron.2016.08.017  0.527
2016 Wess J. Use of Designer G Protein-Coupled Receptors to Dissect Metabolic Pathways. Trends in Endocrinology and Metabolism: Tem. 27: 600-3. PMID 27381463 DOI: 10.1016/J.Tem.2016.04.001  0.402
2016 Shen W, Plotkin JL, Francardo V, Ko WK, Xie Z, Li Q, Fieblinger T, Wess J, Neubig RR, Lindsley CW, Conn PJ, Greengard P, Bezard E, Cenci MA, Surmeier DJ. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. Neuron. 90: 1139. PMID 27253449 DOI: 10.1016/J.Neuron.2016.05.017  0.483
2016 Klepac K, Kilić A, Gnad T, Brown LM, Herrmann B, Wilderman A, Balkow A, Glöde A, Simon K, Lidell ME, Betz MJ, Enerbäck S, Wess J, Freichel M, Blüher M, et al. The Gq signalling pathway inhibits brown and beige adipose tissue. Nature Communications. 7: 10895. PMID 26955961 DOI: 10.1038/Ncomms10895  0.332
2016 Hu J, Stern M, Gimenez LE, Wanka L, Zhu L, Rossi M, Meister J, Inoue A, Beck-Sickinger AG, Gurevich VV, Wess J. A G Protein-Biased Designer G Protein-Coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-Dependent Signaling Pathways. The Journal of Biological Chemistry. PMID 26851281 DOI: 10.1074/Jbc.M115.702282  0.406
2016 Nakajima K, Cui Z, Li C, Meister J, Cui Y, Fu O, Smith AS, Jain S, Lowell BB, Krashes MJ, Wess J. Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake. Nature Communications. 7: 10268. PMID 26743492 DOI: 10.1038/Ncomms10268  0.366
2015 Rossi M, Ruiz de Azua I, Barella LF, Sakamoto W, Zhu L, Cui Y, Lu H, Rebholz H, Matschinsky FM, Doliba NM, Butcher AJ, Tobin AB, Wess J. CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 26598688 DOI: 10.1073/Pnas.1519430112  0.384
2015 Shen W, Plotkin JL, Francardo V, Ko WK, Xie Z, Li Q, Fieblinger T, Wess J, Neubig RR, Lindsley CW, Conn PJ, Greengard P, Bezard E, Cenci MA, Surmeier DJ. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. Neuron. 88: 762-773. PMID 26590347 DOI: 10.1016/J.Neuron.2015.10.039  0.405
2015 Rossi M, Cui Z, Nakajima K, Hu J, Zhu L, Wess J. Virus-Mediated Expression of DREADDs for In Vivo Metabolic Studies. Methods in Molecular Biology (Clifton, N.J.). 1335: 205-21. PMID 26260603 DOI: 10.1007/978-1-4939-2914-6_14  0.409
2015 Gould RW, Dencker D, Grannan M, Bubser M, Zhan X, Wess J, Xiang Z, Locuson C, Lindsley CW, Conn PJ, Jones CK. A role for the M1 muscarinic acetylcholine receptor in top-down cognitive processing using a touchscreen visual discrimination task in mice. Acs Chemical Neuroscience. PMID 26176846 DOI: 10.1021/Acschemneuro.5B00123  0.441
2015 Darby M, Schnoeller C, Vira A, Culley FJ, Culley F, Bobat S, Logan E, Kirstein F, Wess J, Cunningham AF, Brombacher F, Selkirk ME, Horsnell WG. The M3 muscarinic receptor is required for optimal adaptive immunity to helminth and bacterial infection. Plos Pathogens. 11: e1004636. PMID 25629518 DOI: 10.1371/Journal.Ppat.1004636  0.414
2015 Kistemaker LE, van Os RP, Dethmers-Ausema A, Bos IS, Hylkema MN, van den Berge M, Hiemstra PS, Wess J, Meurs H, Kerstjens HA, Gosens R. Muscarinic M3 receptors on structural cells regulate cigarette smoke-induced neutrophilic airway inflammation in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 308: L96-103. PMID 25381025 DOI: 10.1152/Ajplung.00259.2014  0.492
2015 Kaiser E, Schröder L, Wiesen K, Wess J, Tian Q, Kaestner L, Lipp P. Novel Roles of Gq-Dependent Signal Transduction for Cardiac Pacemaking and Cardiac Impulse Propagation Studied by Gq-KO and a DREADD Biophysical Journal. 108: 131a-132a. DOI: 10.1016/J.Bpj.2014.11.732  0.344
2014 Bubser M, Bridges TM, Dencker D, Gould RW, Grannan M, Noetzel MJ, Lamsal A, Niswender CM, Daniels JS, Poslusney MS, Melancon BJ, Tarr JC, Byers FW, Wess J, Duggan ME, et al. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents. Acs Chemical Neuroscience. 5: 920-42. PMID 25137629 DOI: 10.1021/Cn500128B  0.543
2014 Kruse AC, Kobilka BK, Gautam D, Sexton PM, Christopoulos A, Wess J. Muscarinic acetylcholine receptors: novel opportunities for drug development. Nature Reviews. Drug Discovery. 13: 549-60. PMID 24903776 DOI: 10.1038/Nrd4295  0.527
2014 Chen SR, Chen H, Yuan WX, Wess J, Pan HL. Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice. The Journal of Biological Chemistry. 289: 14321-30. PMID 24695732 DOI: 10.1074/Jbc.M114.550384  0.506
2014 Kruse AC, Hu J, Kobilka BK, Wess J. Muscarinic acetylcholine receptor X-ray structures: potential implications for drug development. Current Opinion in Pharmacology. 16: 24-30. PMID 24662799 DOI: 10.1016/J.Coph.2014.02.006  0.517
2014 Procino G, Milano S, Carmosino M, Barbieri C, Nicoletti MC, Li JH, Wess J, Svelto M. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney International. 86: 127-38. PMID 24522493 DOI: 10.1038/Ki.2014.10  0.332
2014 Byun NE, Grannan M, Bubser M, Barry RL, Thompson A, Rosanelli J, Gowrishankar R, Kelm ND, Damon S, Bridges TM, Melancon BJ, Tarr JC, Brogan JT, Avison MJ, Deutch AY, ... Wess J, et al. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1578-93. PMID 24442096 DOI: 10.1038/Npp.2014.2  0.502
2014 Gericke A, Steege A, Manicam C, Böhmer T, Wess J, Pfeiffer N. Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal Investigative Ophthalmology and Visual Science. 55: 625-631. PMID 24408978 DOI: 10.1167/Iovs.13-13549  0.501
2014 Kistemaker LEM, Bos ST, Mudde WM, Hylkema MN, Hiemstra PS, Wess J, Meurs H, Kerstjens HAM, Gosens R. Muscarinic M3 receptors contribute to allergen-induced airway remodeling in mice American Journal of Respiratory Cell and Molecular Biology. 50: 690-698. PMID 24156289 DOI: 10.1165/rcmb.2013-0220OC  0.421
2014 Kruse AC, Li J, Hu J, Kobilka BK, Wess J. Novel insights into M3 muscarinic acetylcholine receptor physiology and structure. Journal of Molecular Neuroscience : Mn. 53: 316-23. PMID 24068573 DOI: 10.1007/S12031-013-0127-0  0.542
2013 Kruse AC, Ring AM, Manglik A, Hu J, Hu K, Eitel K, Hübner H, Pardon E, Valant C, Sexton PM, Christopoulos A, Felder CC, Gmeiner P, Steyaert J, Weis WI, ... ... Wess J, et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature. 504: 101-6. PMID 24256733 DOI: 10.1038/Nature12735  0.501
2013 Hu J, Hu K, Liu T, Stern MK, Mistry R, Challiss RA, Costanzi S, Wess J. Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation. The Journal of Biological Chemistry. 288: 34777-90. PMID 24133207 DOI: 10.1074/Jbc.M113.503714  0.433
2013 Kruse AC, Weiss DR, Rossi M, Hu J, Hu K, Eitel K, Gmeiner P, Wess J, Kobilka BK, Shoichet BK. Muscarinic receptors as model targets and antitargets for structure-based ligand discovery. Molecular Pharmacology. 84: 528-40. PMID 23887926 DOI: 10.1124/Mol.113.087551  0.575
2013 Li JH, Jain S, McMillin SM, Cui Y, Gautam D, Sakamoto W, Lu H, Jou W, McGuinness OP, Gavrilova O, Wess J. A novel experimental strategy to assess the metabolic effects of selective activation of a Gq- coupled receptor in hepatocytes in vivo Endocrinology. 154: 3539-3551. PMID 23861369 DOI: 10.1210/En.2012-2127  0.474
2013 Ferguson SM, Phillips PE, Roth BL, Wess J, Neumaier JF. Direct-pathway striatal neurons regulate the retention of decision-making strategies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11668-76. PMID 23843534 DOI: 10.1523/Jneurosci.4783-12.2013  0.304
2013 Nakajima K, Jain S, de Azua IR, McMillin SM, Rossi M, Wess J. Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells Molecular Endocrinology. 27: 1208-1216. PMID 23820900 DOI: 10.1210/Me.2013-1084  0.472
2013 Wess J, Nakajima K, Jain S. Novel designer receptors to probe GPCR signaling and physiology Trends in Pharmacological Sciences. 34: 385-392. PMID 23769625 DOI: 10.1016/J.Tips.2013.04.006  0.478
2013 Jain S, De Azua IR, Lu H, White MF, Guettier JM, Wess J. Chronic activation of a designer Gq-coupled receptor improves β cell function Journal of Clinical Investigation. 123: 1750-1762. PMID 23478411 DOI: 10.1172/Jci66432  0.397
2013 Kistemaker LEM, Bos IST, Hylkema MN, Nawijn MC, Hiemstra PS, Wess J, Meurs H, Kerstjens HAM, Gosens R. Muscarinic receptor subtype-specific effects on cigarette smoke-induced inflammation in mice European Respiratory Journal. 42: 1677-1688. PMID 23397297 DOI: 10.1183/09031936.00112412  0.415
2013 Arteaga-Solis E, Zee T, Emala CW, Vinson C, Wess J, Karsenty G. Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma. Cell Metabolism. 17: 35-48. PMID 23312282 DOI: 10.1016/J.Cmet.2012.12.004  0.323
2013 Farrell MS, Pei Y, Wan Y, Yadav PN, Daigle TL, Urban DJ, Lee HM, Sciaky N, Simmons A, Nonneman RJ, Huang XP, Hufeisen SJ, Guettier JM, Moy SS, Wess J, et al. A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 854-62. PMID 23303063 DOI: 10.1038/Npp.2012.251  0.38
2013 Forrest D, Wess J. A heartfelt response: new thyroid hormone-sensitive neurons in the hypothalamus. The Journal of Clinical Investigation. 123: 117-20. PMID 23257363 DOI: 10.1172/Jci67448  0.343
2012 Kohlmeier KA, Ishibashi M, Wess J, Bickford ME, Leonard CS. Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus. Journal of Neurophysiology. 108: 2751-66. PMID 22956788 DOI: 10.1152/Jn.01120.2011  0.538
2012 Nakajima KI, Wess J. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor Molecular Pharmacology. 82: 575-582. PMID 22821234 DOI: 10.1124/Mol.112.080358  0.462
2012 De Azua IR, Nakajima KI, Rossi M, Cui Y, Jou W, Gavrilova O, Wess J. Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo Faseb Journal. 26: 4275-4286. PMID 22730439 DOI: 10.1096/Fj.12-204644  0.486
2012 Dencker D, Weikop P, Sørensen G, Woldbye DPD, Wörtwein G, Wess J, Fink-Jensen A. An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine Psychopharmacology. 224: 277-287. PMID 22648127 DOI: 10.1007/S00213-012-2751-8  0.456
2012 Ruiz De Azua I, Gautam D, Jain S, Guettier JM, Wess J. Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors Life Sciences. 91: 986-991. PMID 22525375 DOI: 10.1016/J.Lfs.2012.04.010  0.55
2012 Zheng F, Wess J, Alzheimer C. M 2 muscarinic acetylcholine receptors regulate long-term potentiation at hippocampal CA3 pyramidal cell synapses in an input-specific fashion Journal of Neurophysiology. 108: 91-100. PMID 22490561 DOI: 10.1152/Jn.00740.2011  0.475
2012 Dencker D, Thomsen M, Wörtwein G, Weikop P, Cui Y, Jeon J, Wess J, Fink-Jensen A. Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease. Acs Chemical Neuroscience. 3: 80-89. PMID 22389751 DOI: 10.1021/Cn200110Q  0.777
2012 Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E, Green HF, Liu T, Chae PS, Dror RO, Shaw DE, Weis WI, Wess J, Kobilka BK. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature. 482: 552-6. PMID 22358844 DOI: 10.1038/Nature10867  0.539
2012 Hollenhorst MI, Lips KS, Wolff M, Wess J, Gerbig S, Takats Z, Kummer W, Fronius M. Luminal cholinergic signalling in airway lining fluid: A novel mechanism for activating chloride secretion via Ca 2+-dependent Cl - and K + channels British Journal of Pharmacology. 166: 1388-1402. PMID 22300281 DOI: 10.1111/J.1476-5381.2012.01883.X  0.367
2012 Wess J. Novel muscarinic receptor mutant mouse models Handbook of Experimental Pharmacology. 208: 95-117. PMID 22222697 DOI: 10.1007/978-3-642-23274-9_6  0.518
2012 Guo JD, Hazra R, Dabrowska J, Muly EC, Wess J, Rainnie DG. Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropharmacology. 62: 1671-83. PMID 22166222 DOI: 10.1016/J.Neuropharm.2011.11.013  0.562
2012 Veeraragavan S, Graham D, Bui N, Yuva-Paylor LA, Wess J, Paylor R. Genetic reduction of muscarinic M 4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS) Behavioural Brain Research. 228: 1-8. PMID 22123412 DOI: 10.1016/J.Bbr.2011.11.018  0.534
2012 Hu J, Thor D, Zhou Y, Liu T, Wang Y, McMillin SM, Mistry R, Challiss RAJ, Costanzi S, Wess J. Structural aspects of M3 muscarinic acetylcholine receptor dimer formation and activation Faseb Journal. 26: 604-616. PMID 22031716 DOI: 10.1096/fj.11-191510  0.323
2012 Thomsen M, Lindsley CW, Conn PJ, Wessell JE, Fulton BS, Wess J, Caine SB. Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice Psychopharmacology. 220: 673-685. PMID 21964721 DOI: 10.1007/S00213-011-2516-9  0.769
2012 Dencker D, Thomsen M, Wörtwein G, Weikop P, Cui Y, Jeon J, Wess J, Fink-Jensen A. Muscarinic acetylcholine receptor subtypes as potential drug targets for the treatment of schizophrenia, drug abuse, and Parkinson's disease Acs Chemical Neuroscience. 3: 80-89. DOI: 10.1021/cn200110q  0.65
2011 Challiss RAJ, Wess J. Receptors: GPCR-G protein preassembly? Nature Chemical Biology. 7: 657-658. PMID 21931312 DOI: 10.1038/Nchembio.665  0.367
2011 Bartko SJ, Romberg C, White B, Wess J, Bussey TJ, Saksida LM. Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method. Neuropharmacology. 61: 1366-78. PMID 21903112 DOI: 10.1016/J.Neuropharm.2011.08.023  0.482
2011 Gericke A, Sniatecki JJ, Goloborodko E, Steege A, Zavaritskaya O, Vetter JM, Grus FH, Patzak A, Wess J, Pfeiffer N. Identification of the muscarinic acetylcholine receptor subtype mediating cholinergic vasodilation in murine retinal arterioles Investigative Ophthalmology and Visual Science. 52: 7479-7484. PMID 21873683 DOI: 10.1167/Iovs.11-7370  0.572
2011 Raufman JP, Shant J, Xie G, Cheng K, Gao XM, Shiu B, Shah N, Drachenberg CB, Heath J, Wess J, Khurana S. Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis. 32: 1396-402. PMID 21705482 DOI: 10.1093/Carcin/Bgr118  0.468
2011 McMillin SM, Heusel M, Liu T, Costanzi S, Wess J. Structural basis of M 3 muscarinic receptor dimer/oligomer formation Journal of Biological Chemistry. 286: 28584-28598. PMID 21685385 DOI: 10.1074/Jbc.M111.259788  0.483
2011 Creson TK, Austin DR, Shaltiel G, Mccammon J, Wess J, Manji HK, Chen G. Lithium treatment attenuates muscarinic M1 receptor dysfunction Bipolar Disorders. 13: 238-249. PMID 21676127 DOI: 10.1111/J.1399-5618.2011.00915.X  0.488
2011 Dencker D, Wörtwein G, Weikop P, Jeon J, Thomsen M, Sager TN, Mørk A, Woldbye DPD, Wess J, Fink-Jensen A. Involvement of a subpopulation of neuronal M 4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M 1/M 4 preferring muscarinic receptor agonist xanomeline Journal of Neuroscience. 31: 5905-5908. PMID 21508215 DOI: 10.1523/Jneurosci.0370-11.2011  0.774
2011 Schmidt LS, Thomsen M, Weikop P, Dencker D, Wess J, Woldbye DPD, Wortwein G, Fink-Jensen A. Increased cocaine self-administration in M 4 muscarinic acetylcholine receptor knockout mice Psychopharmacology. 216: 367-378. PMID 21373792 DOI: 10.1007/S00213-011-2225-4  0.75
2011 Gericke A, Sniatecki JJ, Mayer VGA, Goloborodko E, Patzak A, Wess J, Pfeiffer N. Role of m1, m3, and m5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice American Journal of Physiology - Heart and Circulatory Physiology. 300: H1602-H1608. PMID 21335473 DOI: 10.1152/ajpheart.00982.2010  0.425
2011 Fink-Jensen A, Schmidt LS, Dencker D, Schülein C, Wess J, Wörtwein G, Woldbye DPD. Antipsychotic-induced catalepsy is attenuated in mice lacking the M 4 muscarinic acetylcholine receptor European Journal of Pharmacology. 656: 39-44. PMID 21269601 DOI: 10.1016/J.Ejphar.2011.01.018  0.577
2011 Kupchik YM, Barchad-Avitzur O, Wess J, Ben-Chaim Y, Parnas I, Parnas H. A novel fast mechanism for GPCR-mediated signal transduction--control of neurotransmitter release. The Journal of Cell Biology. 192: 137-51. PMID 21200029 DOI: 10.1085/Jgp1372Oia2  0.411
2011 Azua IRd, Gautam D, Guettier JM, Wess J. Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: Therapeutic implications Trends in Endocrinology and Metabolism. 22: 74-80. PMID 21106385 DOI: 10.1016/J.Tem.2010.10.004  0.483
2011 Rosemond E, Rossi M, McMillin SM, Scarselli M, Donaldson JG, Wess J. Regulation of M3 muscarinic receptor expression and function by transmembrane protein 147 Molecular Pharmacology. 79: 251-261. PMID 21056967 DOI: 10.1124/Mol.110.067363  0.365
2010 Kong KC, Butcher AJ, McWilliams P, Jones D, Wess J, Hamdan FF, Werry T, Rosethorne EM, Charlton SJ, Munson SE, Cragg HA, Smart AD, Tobin AB. M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1 Proceedings of the National Academy of Sciences of the United States of America. 107: 21181-21186. PMID 21078968 DOI: 10.1073/Pnas.1011651107  0.537
2010 Chen SR, Chen H, Yuan WX, Wess J, Pan HL. Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice. The Journal of Biological Chemistry. 285: 40427-37. PMID 20940295 DOI: 10.1074/Jbc.M110.176966  0.505
2010 Gautam D, De Azua IR, Li JH, Guettier JM, Heard T, Cui Y, Lu H, Jou W, Gavrilova O, Zawalich WS, Wess J. Beneficial metabolic effects caused by persistent activation of β-cell M3 muscarinic acetylcholine receptors in transgenic mice Endocrinology. 151: 5185-5194. PMID 20843999 DOI: 10.1210/En.2010-0519  0.412
2010 Hu J, Wang Y, Zhang X, Lloyd JR, Li JH, Karpiak J, Costanzi S, Wess J. Structural basis of G protein-coupled receptor-G protein interactions. Nature Chemical Biology. 6: 541-8. PMID 20512139 DOI: 10.1038/Nchembio.385  0.455
2010 Maison SF, Liu XP, Vetter DE, Eatock RA, Nathanson NM, Wess J, Liberman MC. Muscarinic signaling in the cochlea: presynaptic and postsynaptic effects on efferent feedback and afferent excitability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 6751-62. PMID 20463237 DOI: 10.1523/Jneurosci.5080-09.2010  0.523
2010 Poulin B, Butcher A, McWilliams P, Bourgognon JM, Pawlak R, Kong KC, Bottrill A, Mistry S, Wess J, Rosethorne EM, Charlton SJ, Tobin AB. The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner. Proceedings of the National Academy of Sciences of the United States of America. 107: 9440-5. PMID 20439723 DOI: 10.1073/Pnas.0914801107  0.569
2010 De Azua IR, Scarselli M, Rosemond E, Gautam D, Jou W, Gavrilova O, Ebert PJ, Levitt P, Wess J. RGS4 is a negative regulator of insulin release from pancreatic β-cells in vitro and in vivo Proceedings of the National Academy of Sciences of the United States of America. 107: 7999-8004. PMID 20385802 DOI: 10.1073/Pnas.1003655107  0.354
2010 Davis AA, Fritz JJ, Wess J, Lah JJ, Levey AI. Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 4190-6. PMID 20335454 DOI: 10.1523/Jneurosci.6393-09.2010  0.447
2010 Threlfell S, Clements MA, Khodai T, Pienaar IS, Exley R, Wess J, Cragg SJ. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 3398-408. PMID 20203199 DOI: 10.1523/Jneurosci.5620-09.2010  0.46
2010 Khurana S, Shah N, Cheng K, Shiu B, Samimi R, Belo A, Shant J, Drachenberg C, Wess J, Raufman JP. Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. The Journal of Pharmacology and Experimental Therapeutics. 333: 639-49. PMID 20197374 DOI: 10.1124/Jpet.109.165118  0.354
2010 Shi Y, Oury F, Yadav VK, Wess J, Liu XS, Guo XE, Murshed M, Karsenty G. Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metabolism. 11: 231-8. PMID 20197056 DOI: 10.1016/J.Cmet.2010.01.005  0.33
2010 Jeon J, Dencker D, Wörtwein G, Woldbye DP, Cui Y, Davis AA, Levey AI, Schütz G, Sager TN, Mørk A, Li C, Deng CX, Fink-Jensen A, Wess J. A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2396-405. PMID 20147565 DOI: 10.1523/Jneurosci.3843-09.2010  0.534
2010 Wess J. More Is Not Always Better: α2A-Adrenoceptor Expression in Type 2 Diabetes Cell Metabolism. 11: 3-5. PMID 20085729 DOI: 10.1016/J.Cmet.2009.12.002  0.338
2010 Balasubramanian R, Ruiz de Azua I, Wess J, Jacobson KA. Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells. Biochemical Pharmacology. 79: 1317-26. PMID 20067775 DOI: 10.1016/J.Bcp.2009.12.026  0.428
2010 Schlenz H, Kummer W, Jositsch G, Wess J, Krasteva G. Muscarinic receptor-mediated bronchoconstriction is coupled to caveolae in murine airways American Journal of Physiology - Lung Cellular and Molecular Physiology. 298: L626-L636. PMID 20023174 DOI: 10.1152/Ajplung.00261.2009  0.416
2010 Thomsen M, Wess J, Fulton BS, Fink-Jensen A, Caine SB. Modulation of prepulse inhibition through both M1 and M 4 muscarinic receptors in mice Psychopharmacology. 208: 401-416. PMID 20013114 DOI: 10.1007/S00213-009-1740-Z  0.768
2010 Thomsen M, Conn PJ, Lindsley C, Wess J, Boon JY, Fulton BS, Fink-Jensen A, Caine SB. Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation Journal of Pharmacology and Experimental Therapeutics. 332: 959-969. PMID 19996296 DOI: 10.1124/Jpet.109.162057  0.746
2010 Schmidt LS, Miller AD, Lester DB, Bay-Richter C, Schülein C, Frikke-Schmidt H, Wess J, Blaha CD, Woldbye DP, Fink-Jensen A, Wortwein G. Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice. Psychopharmacology. 207: 547-58. PMID 19820917 DOI: 10.1007/S00213-009-1685-2  0.453
2009 Tanahashi Y, Unno T, Matsuyama H, Ishii T, Yamada M, Wess J, Komori S. Multiple muscarinic pathways mediate the suppression of voltage-gated Ca2+ channels in mouse intestinal smooth muscle cells. British Journal of Pharmacology. 158: 1874-83. PMID 20050185 DOI: 10.1111/J.1476-5381.2009.00475.X  0.331
2009 Wright MC, Potluri S, Wang X, Dentcheva E, Gautam D, Tessler A, Wess J, Rich MM, Son YJ. Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14942-55. PMID 19940190 DOI: 10.1523/Jneurosci.2276-09.2009  0.342
2009 Guettier JM, Gautam D, Scarselli M, Ruiz de Azua I, Li JH, Rosemond E, Ma X, Gonzalez FJ, Armbruster BN, Lu H, Roth BL, Wess J. A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proceedings of the National Academy of Sciences of the United States of America. 106: 19197-202. PMID 19858481 DOI: 10.1073/Pnas.0906593106  0.336
2009 Pooput C, Rosemond E, Karpiak J, Deflorian F, Vilar S, Costanzi S, Wess J, Kirk KL. Structural basis of the selectivity of the β2-adrenergic receptor for fluorinated catecholamines Bioorganic and Medicinal Chemistry. 17: 7987-7992. PMID 19857969 DOI: 10.1016/J.Bmc.2009.10.015  0.478
2009 Li JH, Gautam D, Han SJ, Guettier JM, Cui Y, Lu H, Deng C, O'Hare J, Jou W, Gavrilova O, Buettner C, Wess J. Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice Diabetes. 58: 2776-2787. PMID 19752163 DOI: 10.2337/Db09-0522  0.342
2009 Li JH, Chou CL, Li B, Gavrilova O, Eisner C, Schnermann J, Anderson SA, Deng CX, Knepper MA, Wess J. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. The Journal of Clinical Investigation. 119: 3115-26. PMID 19729836 DOI: 10.1172/Jci39680  0.433
2009 Liu QH, Zheng YM, Korde AS, Yadav VR, Rathore R, Wess J, Wang YX. Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle. Proceedings of the National Academy of Sciences of the United States of America. 106: 11418-23. PMID 19549818 DOI: 10.1073/Pnas.0813307106  0.303
2009 Kitazawa T, Asakawa K, Nakamura T, Teraoka H, Unno T, Komori S, Yamada M, Wess J. M3 muscarinic receptors mediate positive inotropic responses in mouse atria: a study with muscarinic receptor knockout mice. The Journal of Pharmacology and Experimental Therapeutics. 330: 487-93. PMID 19429792 DOI: 10.1124/Jpet.109.153304  0.583
2009 Gericke A, Mayer VGA, Steege A, Patzak A, Neumann U, Grus FH, Joachim SC, Choritz L, Wess J, Pfeiffer N. Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice Investigative Ophthalmology and Visual Science. 50: 4822-4827. PMID 19407017 DOI: 10.1167/iovs.09-3600  0.454
2009 Kitamura N, Araya R, Kudoh M, Kishida H, Kimura T, Murayama M, Takashima A, Sakamaki Y, Hashikawa T, Ito S, Ohtsuki S, Terasaki T, Wess J, Yamada M. Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency. Plos One. 4: e5159. PMID 19357782 DOI: 10.1371/Journal.Pone.0005159  0.432
2009 Gautam D, Jeon J, Starost MF, Han SJ, Hamdan FF, Cui Y, Parlow AF, Gavrilova O, Szalayova I, Mezey E, Wess J. Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth. Proceedings of the National Academy of Sciences of the United States of America. 106: 6398-403. PMID 19332789 DOI: 10.1073/Pnas.0900977106  0.541
2009 Klein MK, Haberberger RV, Hartmann P, Faulhammer P, Lips KS, Krain B, Wess J, Kummer W, König P. Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development. The European Respiratory Journal. 33: 1113-21. PMID 19213795 DOI: 10.1183/09031936.00015108  0.567
2009 Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, Kummer W. Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 389-95. PMID 18974978 DOI: 10.1007/S00210-008-0365-9  0.369
2008 Wess J, Han SJ, Kim SK, Jacobson KA, Li JH. Conformational changes involved in G-protein-coupled-receptor activation. Trends in Pharmacological Sciences. 29: 616-25. PMID 18838178 DOI: 10.1016/J.Tips.2008.08.006  0.468
2008 Schliebe N, Strotmann R, Busse K, Mitschke D, Biebermann H, Schomburg L, Köhrle J, Bär J, Römpler H, Wess J, Schöneberg T, Sangkuhl K. V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis. American Journal of Physiology. Renal Physiology. 295: F1177-90. PMID 18715941 DOI: 10.1152/Ajprenal.00465.2007  0.322
2008 Conklin BR, Hsiao EC, Claeysen S, Dumuis A, Srinivasan S, Forsayeth JR, Guettier JM, Chang WC, Pei Y, McCarthy KD, Nissenson RA, Wess J, Bockaert J, Roth BL. Engineering GPCR signaling pathways with RASSLs. Nature Methods. 5: 673-8. PMID 18668035 DOI: 10.1038/Nmeth.1232  0.396
2008 Bonsi P, Martella G, Cuomo D, Platania P, Sciamanna G, Bernardi G, Wess J, Pisani A. Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 6258-63. PMID 18550768 DOI: 10.1523/Jneurosci.1678-08.2008  0.524
2008 Raufman JP, Samimi R, Shah N, Khurana S, Shant J, Drachenberg C, Xie G, Wess J, Cheng K. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer Research. 68: 3573-8. PMID 18483237 DOI: 10.1158/0008-5472.Can-07-6810  0.417
2008 Gautam D, Jeon J, Li JH, Han SJ, Hamdan FF, Cui Y, Lu H, Deng C, Gavrilova O, Wess J. Metabolic roles of the M3 muscarinic acetylcholine receptor studied with M3 receptor mutant mice: a review. Journal of Receptor and Signal Transduction Research. 28: 93-108. PMID 18437633 DOI: 10.1080/10799890801942002  0.579
2008 Wang H, Liang S, Burgdorf J, Wess J, Yeomans J. Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice. Plos One. 3: e1893. PMID 18382674 DOI: 10.1371/Journal.Pone.0001893  0.417
2008 Bainbridge NK, Koselke LR, Jeon J, Bailey KR, Wess J, Crawley JN, Wrenn CC. Learning and memory impairments in a congenic C57BL/6 strain of mice that lacks the M2 muscarinic acetylcholine receptor subtype. Behavioural Brain Research. 190: 50-8. PMID 18346798 DOI: 10.1016/j.bbr.2008.02.001  0.429
2008 Li JH, Hamdan FF, Kim SK, Jacobson KA, Zhang X, Han SJ, Wess J. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy. Biochemistry. 47: 2776-88. PMID 18247581 DOI: 10.1021/Bi7019113  0.564
2008 Kitazawa T, Hirama R, Masunaga K, Nakamura T, Asakawa K, Cao J, Teraoka H, Unno T, Komori S, Yamada M, Wess J, Taneike T. Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle. Naunyn-Schmiedeberg's Archives of Pharmacology. 377: 503-13. PMID 18071676 DOI: 10.1007/S00210-007-0223-1  0.585
2008 Shirey JK, Xiang Z, Orton D, Brady AE, Johnson KA, Williams R, Ayala JE, Rodriguez AL, Wess J, Weaver D, Niswender CM, Conn PJ. An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission. Nature Chemical Biology. 4: 42-50. PMID 18059262 DOI: 10.1038/Nchembio.2007.55  0.526
2008 Hu J, Li J, Costanzi S, Zhang X, Wess J. Mapping of Contact Sites Between the M3 Muscarinic Acetylcholine Receptor and Gq by Cross‐linking Approaches The Faseb Journal. 22: 293-293. DOI: 10.1096/Fasebj.22.2_Supplement.293  0.471
2008 Rosemond E, Scarselli M, De Azua IR, Wess J. Identification of a novel protein partner of the M3 muscarinic acetylcholine receptor The Faseb Journal. 22: 250-250. DOI: 10.1096/Fasebj.22.2_Supplement.250  0.562
2007 LaCroix C, Freeling J, Giles A, Wess J, Li YF. Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. American Journal of Physiology. Heart and Circulatory Physiology. 294: H810-20. PMID 18055517 DOI: 10.1152/AJPHEART.00724.2007  0.348
2007 Gautam D, Han SJ, Duttaroy A, Mears D, Hamdan FF, Li JH, Cui Y, Jeon J, Wess J. Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes, Obesity & Metabolism. 9: 158-69. PMID 17919190 DOI: 10.1111/J.1463-1326.2007.00781.X  0.456
2007 Zhang HM, Zhou HY, Chen SR, Gautam D, Wess J, Pan HL. Control of glycinergic input to spinal dorsal horn neurons by distinct muscarinic receptor subtypes revealed using knockout mice. The Journal of Pharmacology and Experimental Therapeutics. 323: 963-71. PMID 17878406 DOI: 10.1124/Jpet.107.127795  0.494
2007 Wess J, Eglen RM, Gautam D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nature Reviews. Drug Discovery. 6: 721-33. PMID 17762886 DOI: 10.1038/Nrd2379  0.546
2007 Li JH, Han SJ, Hamdan FF, Kim SK, Jacobson KA, Bloodworth LM, Zhang X, Wess J. Distinct structural changes in a G protein-coupled receptor caused by different classes of agonist ligands. The Journal of Biological Chemistry. 282: 26284-93. PMID 17623649 DOI: 10.1074/Jbc.M704875200  0.506
2007 Sakamoto T, Unno T, Kitazawa T, Taneike T, Yamada M, Wess J, Nishimura M, Komori S. Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells. The Journal of Physiology. 582: 41-61. PMID 17463038 DOI: 10.1113/Jphysiol.2007.133165  0.413
2007 Zarghooni S, Wunsch J, Bodenbenner M, Brüggmann D, Grando SA, Schwantes U, Wess J, Kummer W, Lips KS. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sciences. 80: 2308-13. PMID 17337281 DOI: 10.1016/J.Lfs.2007.01.046  0.344
2007 Thomsen M, Wörtwein G, Fink-Jensen A, Woldbye DP, Wess J, Caine SB. Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. Psychopharmacology. 192: 97-110. PMID 17310388 DOI: 10.1007/S00213-006-0682-Y  0.791
2007 Vezys V, Masopust D, Desmarets M, Wess J, Zimring JC. Analysis of CD8+ T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors. Life Sciences. 80: 2330-3. PMID 17286988 DOI: 10.1016/J.Lfs.2007.01.001  0.463
2007 Scarselli M, Li B, Kim SK, Wess J. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. The Journal of Biological Chemistry. 282: 7385-96. PMID 17213190 DOI: 10.1074/Jbc.M610394200  0.42
2007 Li B, Scarselli M, Knudsen CD, Kim SK, Jacobson KA, McMillin SM, Wess J. Rapid identification of functionally critical amino acids in a G protein-coupled receptor. Nature Methods. 4: 169-74. PMID 17206152 DOI: 10.1038/Nmeth990  0.45
2007 Kitazawa T, Hashiba K, Cao J, Unno T, Komori S, Yamada M, Wess J, Taneike T. Functional roles of muscarinic M2 and M3 receptors in mouse stomach motility: studies with muscarinic receptor knockout mice. European Journal of Pharmacology. 554: 212-22. PMID 17113073 DOI: 10.1016/J.Ejphar.2006.10.013  0.533
2007 Li JH, Han S, Hamdan FF, Kim S, Jacobson KA, Bloodworth LM, Zhang X, Wess J. Identification of distinct, ligand‐specific structural changes in a G protein‐coupled receptor The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A425-C  0.409
2007 Rosemond E, Li B, McMillin S, Wess J. A novel strategy to identify proteins that interact with the M3 muscarinic receptor in vivo using the split-ubiquitin system in yeast The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A424-A  0.519
2007 Araya R, Kitamura N, Kimura T, Wess J, Yamada M. Estrogen prevents cerebrovascular deficits by the lack of M5 muscarinic acetylcholine receptor through MAPK activation Neuroscience Research. 58. DOI: 10.1016/J.Neures.2007.06.361  0.56
2006 Gautam D, Duttaroy A, Cui Y, Han SJ, Deng C, Seeger T, Alzheimer C, Wess J. M1-M3 muscarinic acetylcholine receptor-deficient mice: novel phenotypes. Journal of Molecular Neuroscience : Mn. 30: 157-60. PMID 17192665 DOI: 10.1385/Jmn:30:1:157  0.572
2006 Kummer W, Wiegand S, Akinci S, Schinkel AH, Wess J, Koepsell H, Haberberger RV, Lips KS. Role of acetylcholine and muscarinic receptors in serotonin-induced bronchoconstriction in the mouse. Journal of Molecular Neuroscience : Mn. 30: 67-8. PMID 17192631 DOI: 10.1385/Jmn:30:1:67  0.331
2006 Unno T, Matsuyama H, Izumi Y, Yamada M, Wess J, Komori S. Roles of M2 and M3 muscarinic receptors in cholinergic nerve-induced contractions in mouse ileum studied with receptor knockout mice. British Journal of Pharmacology. 149: 1022-30. PMID 17099717 DOI: 10.1038/Sj.Bjp.0706955  0.554
2006 Gautam D, Gavrilova O, Jeon J, Pack S, Jou W, Cui Y, Li JH, Wess J. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metabolism. 4: 363-75. PMID 17084710 DOI: 10.1016/J.Cmet.2006.09.008  0.536
2006 Origlia N, Kuczewski N, Aztiria E, Gautam D, Wess J, Domenici L. Muscarinic acetylcholine receptor knockout mice show distinct synaptic plasticity impairments in the visual cortex. The Journal of Physiology. 577: 829-40. PMID 17023506 DOI: 10.1113/Jphysiol.2006.117119  0.496
2006 Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, Saido TC, Seki K, Itohara S, Kawano M, Tanemura K, Takashima A, Yamada K, Kondoh Y, Kanno I, Wess J, et al. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiology of Disease. 24: 334-44. PMID 16956767 DOI: 10.1016/J.Nbd.2006.07.010  0.44
2006 Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, Deng C, Heard T, Wess J. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metabolism. 3: 449-61. PMID 16753580 DOI: 10.1016/J.Cmet.2006.04.009  0.421
2006 Ward SD, Hamdan FF, Bloodworth LM, Siddiqui NA, Li JH, Wess J. Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor. Biochemistry. 45: 676-85. PMID 16411743 DOI: 10.1021/Bi051503Q  0.492
2006 Zhang HM, Chen SR, Matsui M, Gautam D, Wess J, Pan HL. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice. Molecular Pharmacology. 69: 1048-55. PMID 16365281 DOI: 10.1124/Mol.105.018069  0.508
2006 Allen IC, Hartney JM, Coffman TM, Penn RB, Wess J, Koller BH. Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism. American Journal of Physiology. Lung Cellular and Molecular Physiology. 290: L526-33. PMID 16243899 DOI: 10.1152/Ajplung.00340.2005  0.421
2005 Niebauer RT, Gao ZG, Li B, Wess J, Jacobson KA. Signaling of the Human P2Y(1) Receptor Measured by a Yeast Growth Assay with Comparisons to Assays of Phospholipase C and Calcium Mobilization in 1321N1 Human Astrocytoma Cells. Purinergic Signalling. 1: 241-7. PMID 16467903 DOI: 10.1007/S11302-005-6310-1  0.42
2005 Wess J. Allosteric binding sites on muscarinic acetylcholine receptors. Molecular Pharmacology. 68: 1506-9. PMID 16183853 DOI: 10.1124/Mol.105.019141  0.447
2005 Thomsen M, Woldbye DP, Wörtwein G, Fink-Jensen A, Wess J, Caine SB. Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8141-9. PMID 16148222 DOI: 10.1523/Jneurosci.2077-05.2005  0.706
2005 Goutagny R, Comte JC, Salvert D, Gomeza J, Yamada M, Wess J, Luppi PH, Fort P. Paradoxical sleep in mice lacking M3 and M2/M4 muscarinic receptors. Neuropsychobiology. 52: 140-6. PMID 16110248 DOI: 10.1159/000087560  0.534
2005 Han SJ, Hamdan FF, Kim SK, Jacobson KA, Bloodworth LM, Li B, Wess J. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor. The Journal of Biological Chemistry. 280: 34849-58. PMID 16093246 DOI: 10.1074/Jbc.M506711200  0.534
2005 Trendelenburg AU, Meyer A, Wess J, Starke K. Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice. British Journal of Pharmacology. 145: 1153-9. PMID 15965496 DOI: 10.1038/Sj.Bjp.0706297  0.512
2005 Unno T, Matsuyama H, Sakamoto T, Uchiyama M, Izumi Y, Okamoto H, Yamada M, Wess J, Komori S. M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice. British Journal of Pharmacology. 146: 98-108. PMID 15965495 DOI: 10.1038/Sj.Bjp.0706300  0.56
2005 Khurana S, Yamada M, Wess J, Kennedy RH, Raufman JP. Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent. European Journal of Pharmacology. 517: 103-10. PMID 15964566 DOI: 10.1016/J.Ejphar.2005.05.037  0.458
2005 Xie G, Drachenberg C, Yamada M, Wess J, Raufman JP. Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors. American Journal of Physiology. Gastrointestinal and Liver Physiology. 289: G521-9. PMID 15933222 DOI: 10.1152/Ajpgi.00105.2004  0.549
2005 Kuczewski N, Aztiria E, Gautam D, Wess J, Domenici L. Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice. The Journal of Physiology. 566: 907-19. PMID 15919709 DOI: 10.1113/Jphysiol.2005.089987  0.454
2005 Zimring JC, Kapp LM, Yamada M, Wess J, Kapp JA. Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway. Journal of Neuroimmunology. 164: 66-75. PMID 15913791 DOI: 10.1016/J.Jneuroim.2005.03.018  0.495
2005 Han SJ, Hamdan FF, Kim SK, Jacobson KA, Brichta L, Bloodworth LM, Li JH, Wess J. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor. The Journal of Biological Chemistry. 280: 24870-9. PMID 15870064 DOI: 10.1074/Jbc.M500379200  0.568
2005 Gautam D, Han SJ, Heard TS, Cui Y, Miller G, Bloodworth L, Wess J. Cholinergic stimulation of amylase secretion from pancreatic acinar cells studied with muscarinic acetylcholine receptor mutant mice. The Journal of Pharmacology and Experimental Therapeutics. 313: 995-1002. PMID 15764735 DOI: 10.1124/Jpet.105.084855  0.567
2005 Parnas H, Slutsky I, Rashkovan G, Silman I, Wess J, Parnas I. Depolarization initiates phasic acetylcholine release by relief of a tonic block imposed by presynaptic M2 muscarinic receptors. Journal of Neurophysiology. 93: 3257-69. PMID 15703226 DOI: 10.1152/Jn.01131.2004  0.493
2005 Chen SR, Wess J, Pan HL. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice. The Journal of Pharmacology and Experimental Therapeutics. 313: 765-70. PMID 15665136 DOI: 10.1124/Jpet.104.082537  0.508
2005 Li B, Nowak NM, Kim SK, Jacobson KA, Bagheri A, Schmidt C, Wess J. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of second-site mutations that restore function to a coupling-deficient mutant M3 receptor. The Journal of Biological Chemistry. 280: 5664-75. PMID 15572356 DOI: 10.1074/Jbc.M411623200  0.553
2005 Alzheimer C, Wess J. Muskarinische Acetylcholinrezeptoren und die neuronalen Mechanismen kognitiver Leistungen E-Neuroforum. 11. DOI: 10.1515/Nf-2005-0204  0.437
2004 Seeger T, Fedorova I, Zheng F, Miyakawa T, Koustova E, Gomeza J, Basile AS, Alzheimer C, Wess J. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10117-27. PMID 15537882 DOI: 10.1523/Jneurosci.3581-04.2004  0.522
2004 Gautam D, Heard TS, Cui Y, Miller G, Bloodworth L, Wess J. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice. Molecular Pharmacology. 66: 260-7. PMID 15266016 DOI: 10.1124/Mol.66.2.260  0.589
2004 Chernyavsky AI, Arredondo J, Wess J, Karlsson E, Grando SA. Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptors. The Journal of Cell Biology. 166: 261-72. PMID 15263021 DOI: 10.1083/Jcb.200401034  0.512
2004 Tzavara ET, Bymaster FP, Davis RJ, Wade MR, Perry KW, Wess J, McKinzie DL, Felder C, Nomikos GG. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1410-2. PMID 15231726 DOI: 10.1096/Fj.04-1575Fje  0.508
2004 Duttaroy A, Zimliki CL, Gautam D, Cui Y, Mears D, Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes. 53: 1714-20. PMID 15220195 DOI: 10.2337/Diabetes.53.7.1714  0.505
2004 Khurana S, Chacon I, Xie G, Yamada M, Wess J, Raufman JP, Kennedy RH. Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice. European Journal of Pharmacology. 493: 127-32. PMID 15189773 DOI: 10.1016/J.Ejphar.2004.04.012  0.487
2004 Lamping KG, Wess J, Cui Y, Nuno DW, Faraci FM. Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 1253-8. PMID 15130910 DOI: 10.1161/01.Atv.0000130661.82773.Ca  0.562
2004 Boudinot E, Yamada M, Wess J, Champagnat J, Foutz AS. Ventilatory pattern and chemosensitivity in M1 and M3 muscarinic receptor knockout mice. Respiratory Physiology & Neurobiology. 139: 237-45. PMID 15122990 DOI: 10.1016/J.Resp.2003.10.006  0.533
2004 Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Experimental Cell Research. 294: 534-49. PMID 15023540 DOI: 10.1016/J.Yexcr.2003.12.010  0.444
2004 Sangkuhl K, Schulz A, Römpler H, Yun J, Wess J, Schöneberg T. Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo. Human Molecular Genetics. 13: 893-903. PMID 14998935 DOI: 10.1093/Hmg/Ddh105  0.438
2004 Fisher JT, Vincent SG, Gomeza J, Yamada M, Wess J. Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 711-3. PMID 14977875 DOI: 10.1096/Fj.03-0648Fje  0.521
2004 Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annual Review of Pharmacology and Toxicology. 44: 423-50. PMID 14744253 DOI: 10.1146/Annurev.Pharmtox.44.101802.121622  0.554
2003 Struckmann N, Schwering S, Wiegand S, Gschnell A, Yamada M, Kummer W, Wess J, Haberberger RV. Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Molecular Pharmacology. 64: 1444-1451. PMID 14645675 DOI: 10.1124/Mol.64.6.1444  0.548
2003 Yamada M, Basile AS, Fedorova I, Zhang W, Duttaroy A, Cui Y, Lamping KG, Faraci FM, Deng CX, Wess J. Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology. Life Sciences. 74: 345-53. PMID 14607263 DOI: 10.1016/J.Lfs.2003.09.022  0.611
2003 Fink-Jensen A, Fedorova I, Wörtwein G, Woldbye DP, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A. Role for M5 muscarinic acetylcholine receptors in cocaine addiction. Journal of Neuroscience Research. 74: 91-6. PMID 13130510 DOI: 10.1002/Jnr.10728  0.75
2003 Wess J. Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends in Pharmacological Sciences. 24: 414-20. PMID 12915051 DOI: 10.1016/S0165-6147(03)00195-0  0.555
2003 Schmidt C, Li B, Bloodworth L, Erlenbach I, Zeng FY, Wess J. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that "silence" a constitutively active mutant M3 receptor and greatly impair receptor/G protein coupling. The Journal of Biological Chemistry. 278: 30248-60. PMID 12750375 DOI: 10.1074/Jbc.M304991200  0.56
2003 Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. The European Journal of Neuroscience. 17: 1403-10. PMID 12713643 DOI: 10.1046/J.1460-9568.2003.02588.X  0.551
2003 Slutsky I, Wess J, Gomeza J, Dudel J, Parnas I, Parnas H. Use of knockout mice reveals involvement of M2-muscarinic receptors in control of the kinetics of acetylcholine release. Journal of Neurophysiology. 89: 1954-67. PMID 12686574 DOI: 10.1152/Jn.00668.2002  0.477
2003 Bymaster FP, McKinzie DL, Felder CC, Wess J. Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochemical Research. 28: 437-42. PMID 12675128 DOI: 10.1023/A:1022844517200  0.543
2003 Jagoda EM, Kiesewetter DO, Shimoji K, Ravasi L, Yamada M, Gomeza J, Wess J, Eckelman WC. Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice. Neuropharmacology. 44: 653-61. PMID 12668051 DOI: 10.1016/S0028-3908(03)00050-9  0.489
2003 Chernyavsky AI, Nguyen VT, Arredondo J, Ndoye A, Zia S, Wess J, Grando SA. The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion. Life Sciences. 72: 2069-73. PMID 12628458 DOI: 10.1016/S0024-3205(03)00085-7  0.526
2003 Wess J, Duttaroy A, Gomeza J, Zhang W, Yamada M, Felder CC, Bernardini N, Reeh PW. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: A review Life Sciences. 72: 2047-2054. PMID 12628455 DOI: 10.1016/S0024-3205(03)00082-1  0.613
2003 Trendelenburg AU, Gomeza J, Klebroff W, Zhou H, Wess J. Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice. British Journal of Pharmacology. 138: 469-80. PMID 12569072 DOI: 10.1038/Sj.Bjp.0705053  0.583
2003 Xie G, Yamada M, Wess J, Raufman J. The M1 muscarinic receptor is required for full expression of cholinergic agonist-induced pepsinogen secretion Gastroenterology. 124: A141. DOI: 10.1016/S0016-5085(03)80699-6  0.565
2002 Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, Wess J. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Molecular Pharmacology. 62: 1084-93. PMID 12391271 DOI: 10.1124/Mol.62.5.1084  0.606
2002 Hemrick-Luecke SK, Bymaster FP, Evans DC, Wess J, Felder CC. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 99-103. PMID 12235238 DOI: 10.1124/Jpet.102.036020  0.593
2002 Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America. 99: 11452-7. PMID 12154229 DOI: 10.1073/Pnas.162371899  0.572
2002 Zhang W, Yamada M, Gomeza J, Basile AS, Wess J. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6347-52. PMID 12151512 DOI: 10.1523/Jneurosci.22-15-06347.2002  0.564
2002 Porter AC, Bymaster FP, DeLapp NW, Yamada M, Wess J, Hamilton SE, Nathanson NM, Felder CC. M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Research. 944: 82-9. PMID 12106668 DOI: 10.1016/S0006-8993(02)02721-X  0.576
2002 Hamdan FF, Ward SD, Siddiqui NA, Bloodworth LM, Wess J. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor. Biochemistry. 41: 7647-58. PMID 12056896 DOI: 10.1021/Bi016029C  0.507
2002 Bernardini N, Roza C, Sauer SK, Gomeza J, Wess J, Reeh PW. Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: RC229. PMID 12045234 DOI: 10.1523/Jneurosci.22-12-J0002.2002  0.529
2002 Stengel PW, Yamada M, Wess J, Cohen ML. M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 282: R1443-9. PMID 11959688 DOI: 10.1152/Ajpregu.00486.2001  0.575
2002 Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 1709-17. PMID 11880500 DOI: 10.1523/Jneurosci.22-05-01709.2002  0.57
2002 Fisahn A, Yamada M, Duttaroy A, Gan JW, Deng CX, McBain CJ, Wess J. Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents. Neuron. 33: 615-24. PMID 11856534 DOI: 10.1016/S0896-6273(02)00587-1  0.484
2002 Zhou H, Meyer A, Starke K, Gomeza J, Wess J, Trendelenburg AU. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 365: 112-22. PMID 11819029 DOI: 10.1007/S00210-001-0517-7  0.522
2002 Ward SD, Hamdan FF, Bloodworth LM, Wess J. Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy. The Journal of Biological Chemistry. 277: 2247-57. PMID 11698401 DOI: 10.1074/Jbc.M107647200  0.536
2002 Wess J. Considerations in the design and use of chimeric G protein-coupled receptors. Methods in Enzymology. 343: 295-312. PMID 11665575 DOI: 10.1016/S0076-6879(02)43143-6  0.522
2002 Zeng F, Soldner A, Schöneberg T, Wess J. Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling Journal of Neurochemistry. 72: 2404-2414. PMID 10349850 DOI: 10.1046/J.1471-4159.1999.0722404.X  0.553
2001 Berkeley JL, Gomeza J, Wess J, Hamilton SE, Nathanson NM, Levey AI. M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Molecular and Cellular Neurosciences. 18: 512-24. PMID 11922142 DOI: 10.1006/Mcne.2001.1042  0.499
2001 Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J. Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 14096-101. PMID 11707605 DOI: 10.1073/Pnas.251542998  0.588
2001 Felder CC, Porter AC, Skillman TL, Zhang L, Bymaster FP, Nathanson NM, Hamilton SE, Gomeza J, Wess J, McKinzie DL. Elucidating the role of muscarinic receptors in psychosis. Life Sciences. 68: 2605-13. PMID 11392633 DOI: 10.1016/S0024-3205(01)01059-1  0.548
2001 Shapiro MS, Gomeza J, Hamilton SE, Hille B, Loose MD, Nathanson NM, Roche JP, Wess J. Identification of subtypes of muscarinic receptors that regulate Ca2+ and K+ channel activity in sympathetic neurons. Life Sciences. 68: 2481-7. PMID 11392616 DOI: 10.1016/S0024-3205(01)01042-6  0.566
2001 Bymaster FP, Carter PA, Zhang L, Falcone JF, Stengel PW, Cohen ML, Shannon HE, Gomeza J, Wess J, Felder CC. Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice. Life Sciences. 68: 2473-9. PMID 11392615 DOI: 10.1016/S0024-3205(01)01041-4  0.57
2001 Gomeza J, Zhang L, Kostenis E, Felder CC, Bymaster FP, Brodkin J, Shannon H, Xia B, Duttaroy A, Deng Cx, Wess J. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice Life Sciences. 68: 2457-2466. PMID 11392613 DOI: 10.1016/S0024-3205(01)01039-6  0.63
2001 Erlenbach I, Kostenis E, Schmidt C, Hamdan FF, Pausch MH, Wess J. Functional expression of M(1), M(3) and M(5) muscarinic acetylcholine receptors in yeast. Journal of Neurochemistry. 77: 1327-37. PMID 11389184 DOI: 10.1046/J.1471-4159.2001.00344.X  0.578
2001 Erlenbach I, Kostenis E, Schmidt C, Serradeil-Le Gal C, Raufaste D, Dumont ME, Pausch MH, Wess J. Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis. The Journal of Biological Chemistry. 276: 29382-92. PMID 11375990 DOI: 10.1074/Jbc.M103203200  0.489
2001 Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 410: 207-12. PMID 11242080 DOI: 10.1038/35065604  0.545
2001 Miyakawa T, Yamada M, Duttaroy A, Wess J. Hyperactivity and Intact Hippocampus-Dependent Learning in Mice Lacking the M1Muscarinic Acetylcholine Receptor The Journal of Neuroscience. 21: 5239-5250. DOI: 10.1523/Jneurosci.21-14-05239.2001  0.482
2000 Yun J, Schöneberg T, Liu J, Schulz A, Ecelbarger CA, Promeneur D, Nielsen S, Sheng H, Grinberg A, Deng CX, Wess J. Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. Journal of Clinical Investigation. 106: 1361-1371. PMID 11104789 DOI: 10.1172/Jci9154  0.371
2000 Wess J. Physiological roles of G-protein-coupled receptor kinases revealed by gene-targeting technology. Trends in Pharmacological Sciences. 21: 364-7. PMID 11050310 DOI: 10.1016/S0165-6147(00)01542-X  0.373
2000 Zeng F, Wess J. Molecular aspects of muscarinic receptor dimerization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: S19-31. PMID 11008064 DOI: 10.1016/S0893-133X(00)00146-9  0.587
1999 Shapiro MS, Loose MD, Hamilton SE, Nathanson NM, Gomeza J, Wess J, Hille B. Assignment of muscarinic receptor subtypes mediating G-protein modulation of Ca(2+) channels by using knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 10899-904. PMID 10485923 DOI: 10.1073/pnas.96.19.10899  0.454
1999 Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C, Wess J. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 10483-8. PMID 10468635 DOI: 10.1073/Pnas.96.18.10483  0.626
1999 Zeng F, Wess J. Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers Journal of Biological Chemistry. 274: 19487-19497. PMID 10383466 DOI: 10.1074/Jbc.274.27.19487  0.548
1999 Zeng F, Hopp A, Soldner A, Wess J. Use of a Disulfide Cross-linking Strategy to Study Muscarinic Receptor Structure and Mechanisms of Activation Journal of Biological Chemistry. 274: 16629-16640. PMID 10347230 DOI: 10.1074/Jbc.274.23.16629  0.52
1999 Wess J, Blin N, Mutschler E, Blüml K. Muscarinic acetylcholine receptors: structural basis of ligand binding and G protein coupling. Life Sciences. 56: 915-22. PMID 10188793 DOI: 10.1016/0024-3205(95)00028-5  0.555
1999 Kostenis E, Zeng F, Wess J. Structure-function analysis of muscarinic receptors and their associated G proteins Life Sciences. 64: 355-362. PMID 10069496 DOI: 10.1016/S0024-3205(98)00574-8  0.534
1999 Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 1692-7. PMID 9990086 DOI: 10.1073/Pnas.96.4.1692  0.623
1999 Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacology & Therapeutics. 80: 231-64. PMID 9888696 DOI: 10.1016/S0163-7258(98)00030-8  0.445
1999 Jakubik J, Wess J. Use Of A Sandwich Enzyme-Linked Immunosorbent Assay Strategy To Study Mechanisms Of G Protein-Coupled Receptor Assembly Journal of Biological Chemistry. 274: 1349-1358. PMID 9880506 DOI: 10.1074/Jbc.274.3.1349  0.565
1999 Zeng F, Wess J. Development of a disulfide cross-linking strategy to study muscarinic receptor structure Life Sciences. 64: 565. DOI: 10.1016/S0024-3205(99)90485-X  0.422
1998 Schöneberg T, Kostenis E, Liu J, Gudermann T, Wess J. Molecular aspects of vasopressin receptor function Advances in Experimental Medicine and Biology. 449: 347-358. PMID 10026824 DOI: 10.1007/978-1-4615-4871-3_44  0.485
1998 Zhu X, Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry. 37: 15773-15784. PMID 9843382 DOI: 10.1021/Bi981162Z  0.476
1998 Erlenbach I, Wess J. Molecular Basis of V2 Vasopressin Receptor/GsCoupling Selectivity Journal of Biological Chemistry. 273: 26549-26558. PMID 9756892 DOI: 10.1074/Jbc.273.41.26549  0.484
1998 Kostenis E, Zeng F, Wess J. Functional Characterization of a Series of Mutant G Protein αq Subunits Displaying Promiscuous Receptor Coupling Properties Journal of Biological Chemistry. 273: 17886-17892. PMID 9651394 DOI: 10.1074/Jbc.273.28.17886  0.487
1997 Kostenis E, Gomeza J, Lerche C, Wess J. Genetic analysis of receptor-Galphaq coupling selectivity. The Journal of Biological Chemistry. 272: 23675-81. PMID 9295309 DOI: 10.1074/Jbc.272.38.23675  0.536
1997 Schöneberg T, Sandig V, Wess J, Gudermann T, Schultz G. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer: Molecular basis and clinical implication Journal of Clinical Investigation. 100: 1547-1556. PMID 9294123 DOI: 10.1172/Jci119678  0.453
1997 Wess J, Liu J, Blin N, Yun J, Lerche C, Kostenis E. Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems. Life Sciences. 60: 1007-14. PMID 9121341 DOI: 10.1016/S0024-3205(97)00041-6  0.536
1997 Kostenis E, Conklin BR, Wess J. Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits. Biochemistry. 36: 1487-95. PMID 9063897 DOI: 10.1021/Bi962554D  0.462
1997 Wess J, Blin N, Yun J, Schöneberg T, Liu J. Molecular aspects of muscarinic receptor assembly and function. Progress in Brain Research. 109: 153-62. PMID 9009702 DOI: 10.1016/S0079-6123(08)62097-X  0.489
1997 Wess J. Molecular biology of muscarinic acetylcholine receptors. Critical Reviews in Neurobiology. 10: 69-99. PMID 8853955 DOI: 10.1615/Critrevneurobiol.V10.I1.40  0.464
1997 Hou X, Wehrle J, Menge W, Ciccarelli E, Wess J, Mutschler E, Lambrecht G, Timmerman H, Waelbroeck M. Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors. British Journal of Pharmacology. 117: 955-61. PMID 8851517 DOI: 10.1111/J.1476-5381.1996.Tb15287.X  0.516
1997 Wess J. G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition The Faseb Journal. 11: 346-354. DOI: 10.1096/Fasebj.11.5.9141501  0.446
1996 Wenkert D, Schoneberg T, Merendino JJ, Rodriguez Pena MS, Vinitsky R, Goldsmith PK, Wess J, Spiegel AM. Functional characterization of five V2 vasopressin receptor gene mutations. Molecular and Cellular Endocrinology. 124: 43-50. PMID 9027323 DOI: 10.1016/S0303-7207(96)03926-3  0.422
1996 Singer-Lahat D, Liu J, Wess J, Felder CC. The third intracellular domain of the m3 muscarinic receptor determines coupling to calcium influx in transfected Chinese hamster ovary cells. Febs Letters. 386: 51-4. PMID 8635603 DOI: 10.1016/0014-5793(96)00398-5  0.536
1996 Liu J, Blin N, Conklin BR, Wess J. Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis. The Journal of Biological Chemistry. 271: 6172-8. PMID 8626406 DOI: 10.1074/Jbc.271.11.6172  0.564
1996 Liu J, Wess J. Different Single Receptor Domains Determine the Distinct G Protein Coupling Profiles of Members of the Vasopressin Receptor Family Journal of Biological Chemistry. 271: 8772-8778. PMID 8621513 DOI: 10.1074/Jbc.271.15.8772  0.487
1996 Schoneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co‐expressed receptor polypeptide. The Embo Journal. 15: 1283-1291. DOI: 10.1002/J.1460-2075.1996.Tb00470.X  0.489
1995 Liu J, Conklin BR, Blin N, Yun J, Wess J. Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proceedings of the National Academy of Sciences of the United States of America. 92: 11642-6. PMID 8524820 DOI: 10.1073/Pnas.92.25.11642  0.501
1995 Kim J, Wess J, van Rhee AM, Schöneberg T, Jacobson KA. Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor. The Journal of Biological Chemistry. 270: 13987-97. PMID 7775460 DOI: 10.1074/Jbc.270.23.13987  0.446
1995 Mutschler E, Moser U, Wess J, Lambrecht G. Muscarinic receptor subtypes — pharmacological, molecular biological and therapeutical aspects Pharmaceutica Acta Helvetiae. 69: 243-258. PMID 7651968 DOI: 10.1016/0031-6865(94)00045-W  0.475
1995 Liu J, Schöneberg T, Rhee Mv, Wess J. Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors Journal of Biological Chemistry. 270: 19532-19539. PMID 7642637 DOI: 10.1074/Jbc.270.33.19532  0.561
1995 Schöneberg T, Liu J, Wess J. Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor Journal of Biological Chemistry. 270: 18000-18006. PMID 7629108 DOI: 10.1074/Jbc.270.30.18000  0.529
1995 Blin N, Wess J. Mapping of muscarinic receptor domains conferring specificity of coupling to Gq Life Sciences. 56: 1032. DOI: 10.1016/0024-3205(95)93776-B  0.382
1994 Bluml K, Mutschler E, Wess J. Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling Proceedings of the National Academy of Sciences of the United States of America. 91: 7980-7984. PMID 8058746 DOI: 10.1073/Pnas.91.17.7980  0.496
1993 Wess J. Mutational analysis of muscarinic acetylcholine receptors: structural basis of ligand/receptor/G protein interactions. Life Sciences. 53: 1447-63. PMID 8412508 DOI: 10.1016/0024-3205(93)90618-D  0.535
1993 Maggio R, Vogel Z, Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors Proceedings of the National Academy of Sciences of the United States of America. 90: 3103-3107. PMID 8385357 DOI: 10.1073/Pnas.90.7.3103  0.56
1993 Wess J. Molecular basis of muscarinic acetylcholine receptor function. Trends in Pharmacological Sciences. 14: 308-13. PMID 8249149 DOI: 10.1016/0165-6147(93)90049-P  0.549
1993 Vogel Z, Maggio R, Palmer J, Wess J. Conserved threonine and tyrosine residues play important roles in acetylcholine binding and muscarinic receptor activation Life Sciences. 52: 558. DOI: 10.1016/0024-3205(93)90333-X  0.43
1993 Maggio R, Vogel Z, Nanavati S, Wess J. Coexpression of N- and C- terminal muscarinic receptor domains results in functional receptors Life Sciences. 52: 558. DOI: 10.1016/0024-3205(93)90332-W  0.436
1993 Wess J, Nanavati S, Vogel Z, Maggio R. Mutational analysis of the m3 muscarinic receptor: Functional role of proline residues that are highly conserved among all G protein-coupled receptors Life Sciences. 52: 557. DOI: 10.1016/0024-3205(93)90331-V  0.53
1992 Felder CC, Poulter MO, Wess J. Muscarinic receptor-operated Ca2+ influx in transfected fibroblast cells is independent of inositol phosphates and release of intracellular Ca2+. Proceedings of the National Academy of Sciences of the United States of America. 89: 509-13. PMID 1731321 DOI: 10.1073/PNAS.89.2.509  0.321
1991 Angeli P, Brasili L, Cantalamessa F, Marucci G, Wess J. Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation. Naunyn-Schmiedeberg's Archives of Pharmacology. 342: 625-9. PMID 2096296 DOI: 10.1007/BF00175704  0.477
1990 Mutschler E, Feifel R, Moser U, Tacke R, Wess J, Lambrecht G. Muscarinic receptor subtypes European Journal of Pharmacology. 183: 117-119. DOI: 10.1016/0014-2999(90)91384-N  0.51
1988 Wess J, Angeli P, Melchiorre C, Moser U, Mutschler E, Lambrecht G. Methoctramine selectively blocks cardiac muscarinic M2 receptors in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 246-9. PMID 3057387 DOI: 10.1007/BF00173395  0.449
1988 Eltze M, Gmelin G, Wess J, Strohmann C, Tacke R, Mutschler E, Lambrecht G. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type. European Journal of Pharmacology. 158: 233-242. PMID 2472963 DOI: 10.1016/0014-2999(88)90072-6  0.533
1986 Lambrecht G, Moser U, Mutschler E, Walther G, Wess J. Muscarinic ganglionic stimulants: conformationally restrained analogues related to [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. Journal of Medicinal Chemistry. 29: 1309-1311. PMID 3806582 DOI: 10.1021/Jm00157A036  0.396
Show low-probability matches.